| Neigatha Elease Graney, MD | |
|
8550 W Grand River Ave, Suite 300, Brighton, MI 48116-4352 | |
| (810) 220-3700 | |
| (810) 220-1321 |
| Full Name | Neigatha Elease Graney |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 8550 W Grand River Ave, Brighton, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043392905 | NPI | - | NPPES |
| 2981150 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 4301049607 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Neigatha Elease Graney, MD 6832 Chadwick Dr, Canton, MI 48187-1634 Ph: (734) 459-1219 | Neigatha Elease Graney, MD 8550 W Grand River Ave, Suite 300, Brighton, MI 48116-4352 Ph: (810) 220-3700 |
News Archive
ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to establish novel human cell-based models of non-alcoholic fatty liver disease (NAFLD) that will be useful for basic research and as a potential drug development platform. The project stems from recent efforts at ZenBio, Inc. to develop methods for differentiating adipose tissue derived progenitor cells into hepatocyte-like cells.
In 2012, Belgium scientists published a study that concluded that repeated bouts of intensive endurance exercise at the elite level may result in the pathological enlargement of the right ventricle, which, according to the article, is associated with potential health hazards including sudden cardia death.
Research at the University of Surrey has now shown that if a vitamin E supplement is taken with a low-fat meal, the absorption of the vitamin into the blood stream, and therefore its efficacy, is significantly reduced.
Patient Engagement Systems, a nationally recognized leader in developing technology to identify, and monitor individuals with chronic kidney disease, today introduced the Patient Engagement Systems' ESRD Prevention Program which uses proprietary technology including automated physician-patient engagement, analytics, and decision support tools to identify patients with undiagnosed chronic kidney disease and tools to monitor them in order to prevent or delay the progression to ESRD.
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.
› Verified 2 days ago
Julia Elizabeth Madison-williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8001 Challis Rd, Brighton, MI 48116 Phone: 810-227-9510 | |
Christopher Kottke, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2305 Genoa Business Park Dr, Suite 240, Brighton, MI 48114 Phone: 810-494-6820 Fax: 810-229-0747 | |
April Joy Ping, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8548 W Grand River Ave, Brighton, MI 48116 Phone: 810-229-7257 Fax: 810-229-4069 | |
Dr. Penny S Baumeier, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8548 W Grand River Ave, Brighton, MI 48116 Phone: 810-229-7257 | |
Dr. Mary Khunger, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2305 Genoa Business Park Dr, Suite 240, Brighton, MI 48114 Phone: 810-494-6820 Fax: 810-229-0747 | |
Dr. Jennifer Glamann, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8001 Challis Road, Brighton, MI 48116 Phone: 810-227-9510 Fax: 734-764-2599 |